Intracellular Consequences Of Amyloid In Alzheimers Disease.php Book PDF, EPUB Download & Read Online Free

Intracellular Consequences of Amyloid in Alzheimer's Disease
Author: Michael R. D'Andrea
Publisher: Academic Press
ISBN: 012804330X
Pages: 220
Year: 2016-02-21
View: 222
Read: 1086
Consequences of Intracellular Amyloid in Alzheimer’s Disease addresses one of the more currently unresolved aspects confounding Alzheimer’s research, the significance of intraneuronal amyloid. It seeks to explain some of the unresolved questions concerning intracellular amyloid and its origin, entry, and toxicity. Following up on Dr. D’Andrea’s first book, Bursting Neurons and Fading Memories: An Alternative Hypothesis for the Pathogenesis of Alzheimer’s Disease, this book further examines the Inside-Out or Bursting alternative hypothesis of how amyloid escapes the circulatory system to ultimately enter neurons, also examining whether there is a relationship between intracellular amyloid, amyloid plaques, and cognitive impairment. Through a comprehensive explanation of the currently relevant scientific research on intracellular amyloid compiled in this handy reference, readers will better understand the mechanisms that lead to neuron death. Presents the latest research on the significance of intracellular amyloid as it relates to Alzheimer’s Addresses crucial questions about intracellular amyloid, including how if forms and enters neurons, its toxicity, if it triggers cell death, and how amyloid plaques are formed Examines the potential relationship between intracellular amyloid, plaques, and cognitive impairment in an effort to answer whether Alzheimer’s is initially a problem of amyloid, the neuron, or of the blood-brain barrier Seeks to help researchers generate additional alternative therapeutic opportunities to cure Alzheimer’s
Alzheimer's and Parkinson's Diseases
Author: Abraham Fisher, Israel Hanin, Werner Poewe, Manfred Windisch
Publisher: Karger Medical and Scientific Publishers
ISBN: 380558282X
Pages: 363
Year: 2007
View: 157
Read: 301
This issue is a dedicated supplement published in addition to the regular issues of 'Neurodegenerative Diseases' containing congress abstracts. 'Neurodegenerative Diseases' is a well-respected, international peer-reviewed journal in Neurology. Supplement issues are included in the subscription.
Research Progress in Alzheimer's Disease and Dementia
Author: Miao-Kun Sun
Publisher: Nova Publishers
ISBN: 1600219608
Pages: 438
Year: 2008-03-01
View: 676
Read: 180
Alzheimer's disease (AD), the most common form of neurodegenerative disorder in the elderly, is characterised pathologically by extracellular amyloid plaques and intracellular neurofibrillary tangles, pathophysiologically by synaptic dysfunction, and clinically by a progressive decline in cognition. Currently, AD has no cure and its prevalence is predicted to triple by 2050 with the rapid increase in the ageing population, unless more effective treatments are developed. Since the publication of the second book volume, the rapid progress in the research fields of AD and dementia continues through the intensive efforts of research scientists worldwide.This third book volume contains 15 chapters, bringing together a presentation of research frontiers in current AD/dementia research. The topics include molecular genetics of AD, gene expression abnormalities in AD progression, presenilins, taupathy in AD, single - induced(neuron gene expression abnormalities in AD, intracellular A neurodegeneration, roles of lipoprotein receptors in AD onset and progression, cholesterol and tau hyperphosphorylation, AD diagnostics and therapeutic strategies, in vivo visualisation of amyloid-like structures, cathepsin B, antiamyloidogenesis and neuroprotection, environmental enrichment, Fragile X mental retardation gene and dementia, category learning in Parkinson's disease, cerebrovascular disease and dementia, and dementia and hypertension.These chapters cover current advances in our understanding of the pathogenic mechanisms underlying AD and dementia, in the diagnosis of early AD and dementia, and in the development of therapeutic agents that target memory-relevant AD pathogenesis. The book will be highly valuable to students and scientists worldwide who are interested in the scientific research progress in AD and dementia.
Amyloid Proteins
Author: Einar M. Sigurdsson
Publisher: Springer Science & Business Media
ISBN: 1588293378
Pages: 392
Year: 2005-01
View: 723
Read: 677
A proven collection of readily reproducible techniques for studying amyloid proteins and their involvement in the etiology, pathogenesis, diagnosis, and therapy of amyloid diseases. The contributors provide methods for the preparation of amyloid and its precursors (oligomers and protofibrils), in vitro assays and analytical techniques for their study, and cell culture models and assays for the production of amyloid proteins. Additional chapters present readily reproducible techniques for amyloid extraction from tissue, its detection in vitro and in vivo, as well as nontransgenic methods for developing amyloid mouse models. The protocols follow the successful Methods in Molecular Biology⢠series format, each offering step-by-step laboratory instructions, an introduction outlining the principle behind the technique, lists of the necessary equipment and reagents, and tips on troubleshooting and avoiding known pitfalls.
Basic Neurochemistry
Author: Scott T. Brady, George J. Siegel
Publisher: Academic Press
ISBN: 0123749476
Pages: 1096
Year: 2012
View: 1238
Read: 1147
Includes bibliographical references and index.
The Physiological Functions of the Amyloid Precursor Protein Gene Family
Author: Ulrike C. Müller, Thomas Deller
Publisher: Frontiers Media SA
ISBN: 2889453553
Pages:
Year: 2017-12-28
View: 800
Read: 1225
The amyloid precursor protein APP plays a key role in the pathogenesis of Alzheimer’s disease (AD), as proteolytical cleavage of APP gives rise to the Aβ peptide which is deposited in the brains of Alzheimer patients. Despite this, our knowledge of the normal cell biological and physiological functions of APP and the closely related APLPs is limited. This may have hampered our understanding of AD, since evidence has accumulated that not only the production of the Aβ peptide but also the loss of APP-mediated functions may contribute to AD pathogenesis. Thus, it appears timely and highly relevant to elucidate the functions of the APP gene family from the molecular level to their role in the intact organism, i.e. in the context of nervous system development, synapse formation and adult synapse function, as well as neural homeostasis and aging. Why is our understanding of the APP functions so limited? APP and the APLPs are multifunctional proteins that undergo complex proteolytical processing. They give rise to an almost bewildering array of different fragments that may each subserve specific functions. While Aβ is aggregation prone and neurotoxic, the large secreted ectodomain APPsα - produced in the non-amyloidogenic α-secretase pathway - has been shown to be neurotrophic, neuroprotective and relevant for synaptic plasticity, learning and memory. Recently, novel APP cleavage pathways and enzymes have been discovered that have gained much attention not only with respect to AD but also regarding their role in normal brain physiology. In addition to the various cleavage products, there is also solid evidence that APP family proteins mediate important functions as transmembrane cell surface molecules, most notably in synaptic adhesion and cell surface signaling. Elucidating in more detail the molecular mechanisms underlying these divers functions thus calls for an interdisciplinary approach ranging from the structural level to the analysis in model organisms. Thus, in this research topic of Frontiers we compile reviews and original studies, covering our current knowledge of the physiological functions of this intriguing and medically important protein family.
The Year in Neurology 2
Author: Richard T. Johnson
Publisher: John Wiley & Sons
ISBN: 1573317802
Pages: 252
Year: 2010-02-15
View: 1120
Read: 878
This second volume in The Year in Neurology series focuses on present reviews covering novel approaches to our understanding neurological diseases through both basic science and clinical approaches. A wide-range of topics is covered within this volume, including: vertebrobasilar dolichoectasia neurological nanotechnology neurologic diseases sleep disorders chronic inflammatory diseases NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
Understanding Alzheimer's
Author: Prof Ralph Martins
Publisher: Macmillan Publishers Aus.
ISBN: 1743289510
Pages: 352
Year: 2013-09-01
View: 725
Read: 963
Understanding Alzheimer's is a practical guide for the hundreds of thousands of Australians dealing with this extremely challenging condition. Each week, 1500 Australians are diagnosed with Alzheimer's or a dementia-related illness. This timely book answers many of the common questions asked by carers, patients and the public, including: · How is Alzheimer's diagnosed? · Is it possible to prevent and/or slow down the disease? · What are the risk factors for contracting Alzheimer's? · What are the best current treatments, and what is the research telling us about new treatments? · How can diet, physical activity and mental exercise be used to help manage the disease? · What are the emotional and legal issues around caring for someone with Alzheimer's? Drawing on some of Australia's top experts in the field, and containing numerous personal stories and a section on where to get help, this guide offers the best and latest medical information as well as compassionate and reassuring advice for those whose lives are affected by Alzheimer's.
Zinc Signaling in Physiology and Pathogenesis
Author: Toshiyuki Fukada, Taiho Kambe
Publisher: MDPI
ISBN: 3038428213
Pages: 292
Year: 2018-05-04
View: 1141
Read: 209
This book is a printed edition of the Special Issue "Zinc Signaling in Physiology and Pathogenesis" that was published in IJMS
Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders
Author: M.M. Verbeek, R.M. de Waal, Harry V. Vinters
Publisher: Springer Science & Business Media
ISBN: 9401710074
Pages: 358
Year: 2013-06-29
View: 1265
Read: 1146
Cerebral amyloid angiopathy (CAA) is a distinctive abnormality of small cerebral blood vessels, one that has intrigued neuroscientists for decades. The time seems right for a book which examines the phenomenon of CAA using a multifaceted approach: What does it produce clinically? How might CAA be imaged? What are the crucial biochemical/cellular events within cerebral vessel walls that lead to CAA? How can in vitro or transgenic experimental systems be used to understand the etiology of, or even potential treatments for, CAA? The editors have assembled key figures in the field of CAA research to examine these (and other) questions in a series of focused chapters that address specific issues of importance in understanding CAA and its clinical manifestations. Comprehending the biology and pathogenesis of this fascinating vascular lesion may even provide clues to less common forms of cerebral microvascular disease that have been recognized for decades (hypertensive microangiopathy) or more recently (CADASIL).
Cognitive Aging
Author: Institute of Medicine, Board on Health Sciences Policy, Committee on the Public Health Dimensions of Cognitive Aging
Publisher: National Academies Press
ISBN: 0309368650
Pages: 330
Year: 2015-07-21
View: 1084
Read: 965
For most Americans, staying "mentally sharp" as they age is a very high priority. Declines in memory and decision-making abilities may trigger fears of Alzheimer's disease or other neurodegenerative diseases. However, cognitive aging is a natural process that can have both positive and negative effects on cognitive function in older adults - effects that vary widely among individuals. At this point in time, when the older population is rapidly growing in the United States and across the globe, it is important to examine what is known about cognitive aging and to identify and promote actions that individuals, organizations, communities, and society can take to help older adults maintain and improve their cognitive health. Cognitive Aging assesses the public health dimensions of cognitive aging with an emphasis on definitions and terminology, epidemiology and surveillance, prevention and intervention, education of health professionals, and public awareness and education. This report makes specific recommendations for individuals to reduce the risks of cognitive decline with aging. Aging is inevitable, but there are actions that can be taken by individuals, families, communities, and society that may help to prevent or ameliorate the impact of aging on the brain, understand more about its impact, and help older adults live more fully and independent lives. Cognitive aging is not just an individual or a family or a health care system challenge. It is an issue that affects the fabric of society and requires actions by many and varied stakeholders. Cognitive Aging offers clear steps that individuals, families, communities, health care providers and systems, financial organizations, community groups, public health agencies, and others can take to promote cognitive health and to help older adults live fuller and more independent lives. Ultimately, this report calls for a societal commitment to cognitive aging as a public health issue that requires prompt action across many sectors.
Pharmacological Mechanisms in Alzheimer's Therapeutics
Author: Claudio Cuello
Publisher: Springer Science & Business Media
ISBN: 0387715223
Pages: 324
Year: 2007-12-22
View: 348
Read: 1097
The need for effective therapy to treat Alzheimer’s disease is greater than ever, but there is still no drug therapy that can stop or reverse the progression of the disease. There is, however, a great deal of anticipation over the imminent development of effective therapies as a result of the identification of promising targets for drug development. This book investigates these targets and examines ongoing strategies to develop effective therapies for this devastating neurodegenerative condition.
The Big Book on Small Heat Shock Proteins
Author: Robert M Tanguay, Lawrence E. Hightower
Publisher: Springer
ISBN: 331916077X
Pages: 610
Year: 2015-06-15
View: 503
Read: 152
Based upon a workshop entitled “The Small HSP World” held in Québec 2-5 October 2014. Twenty-five scientists provided chapters for the book. The chapters are from the best scientists currently working in this field. These colleagues include Arrigo, Benesch, Benjamin, Buchner-Haslbeck-Weinkauf, Benndorf, Boelens, Carra, Chang, Currie, Ecroyd, Emanuelsson, Fu, Garrido, Golenhofen, Gusev, Hightower, Kampinga, Lavoie, MacRae, Quinlan, Tanguay, Vierling, Vigh, Weeks and Wu. Briefly, the book starts with the structure of small heat shock proteins, moving to their functions and finishing with their involvement in diseases. Although this is quite broad, the structural aspect will be the unifying theme of the book.
The Hippocampus
Author: Robert L. Isaacson, Karl H. Pribram
Publisher: Plenum Publishing Corporation
ISBN:
Pages: 398
Year: 1986
View: 1050
Read: 1137

Clinical Manual of Alzheimer Disease and Other Dementias
Author: Myron F. Weiner, Anne M. Lipton
Publisher: American Psychiatric Pub
ISBN: 1585629618
Pages: 470
Year: 2012-02-24
View: 783
Read: 659
In Clinical Manual of Alzheimer Disease and Other Dementias, practicing psychiatrists and neurologists provide essential input into neuropsychiatric assessment and the diagnosis and treatment of a wide range of neuropsychiatric conditions, including Alzheimer disease and traumatic brain injury. The manual provides invaluable information on both evaluation/diagnosis and treatment. Case studies offer real-life clinical experiences by some of the country's leading experts in the field. Clinical Manual of Alzheimer Disease and Other Dementias Includes DSM-IV-TR cognitive disorders and addresses other cognitive syndromes and psychiatric symptoms that may confound diagnosis. Provides clinical insights into the diagnostic signs and symptoms of dementing illnesses, including Alzheimer disease, frontotemporal dementias, delirium, amnesia, and other cognitive disorders. Reviews the psychiatric syndromes that are related to dementing illnesses and deals with their treatment. Discusses the detection and management of depression in the evaluation of a person with a cognitive complaint or symptoms. Emphasizes the behavioral disorders that accompany dementing illness and presents an approach to their pharmacological and nonpharmacological management. Delineates clinical workup for medical conditions that may underly cognitive or other psychiatric symptoms. Provides an overview of clinical tools and techniques for diagnosing cognitive dysfunction, including history taking, mental status evaluation, physical and neurological examination, and neuropsychological testing. Presents an illustrated review of the most current techniques of neuroimaging in differential diagnosis. Includes key clinical points in every chapter summarizing important concepts. In addition to topics covered in the textbook, the manual includes a chapter on community resources to enable clinicians to better support patients and families through local and national organizations and agencies. This text is a must-have reference for clinical psychiatrists, resident fellows, residents in training, medical students in psychiatry rotations, clinical psychologists, and psychiatric nurses.